India postponed exams for trainee doctors and nurses on May 3, freeing them up to fight the world’s biggest surge in coronavirus infections, as the health system crumbles under the weight of new cases and hospitals run out of beds and oxygen.

Passage Bio Inc. and InformedDNA announced a collaboration to provide no-cost genetic counseling and testing for adults who have been diagnosed by their physicians with Frontotemporal Dementia (FTD).

Treating Covid-19 patients at home with a commonly used inhaled asthma drug called budesonide can speed up their recovery, according to UK trial results on April 12 which doctors said could change the way the disease is treated around the world.

Studies have concluded that chatbots have the potential in treating mental health issues and could be used as an effective tool for delivering cognitive behavioral therapy.

Three major U.S. drug distributors requested the government to expand the Covid-19 vaccine supply chain network as the country strives to immunize its population against the novel coronavirus as quickly as possible.

A study published in JAMA suggests that treatment with vitamin C, in addition to thiamine and hydrocortisone, does not improve treatment outcomes in hospitalized patients with sepsis.

The COVID-19 pandemic has redefined what it means and what it takes to be a healthcare provider in a time of crisis. In a new study from McCann Health, the data from the original 2016 Truth About Doctors study was re-examined and updated, highlighting the need to focus on prioritizing the health and wellbeing of physicians to ultimately help foster a healthier public.

Committed to serving the COPD community, AstraZeneca’s BREZTRI team is unveiling their latest, direct-to-consumer US advertising campaign, “Get Real.”

If organizations want to maintain a trustworthy image and connect with their customers, transparency in the pharmaceutical industry needs to become a higher priority. One way to address this situation is to highlight the commitment to ingredient traceability.

U.S. President-elect Joe Biden said he would order increased production of syringes and other supplies to ramp up vaccinations against Covid-19 and improve upon the Trump administration rollout that he called a “dismal failure.”